Whitehead Institute researchers have elucidated how the growth - regulating metabolic pathway known as mTORC1 (
for mechanistic target of rapamycin complex 1) senses the amino acid arginine.
Not exact matches
«Having identified a link between cytoskeleton dynamics and Zika virus replication, together with the plethora of available cytoskeleton -
targeting compounds, might contribute to gain
mechanistic insight into the ZIKV replication cycle and identify new avenues
for treatment,» Bartenschlager says.
Known as much
for its complexity as its vital role in regulating cellular and organismal growth, the
mechanistic target of rapamycin complex 1 (mTORC1) pathway has seemingly been acting in mysterious ways.
This study is good example of a precision medicine themed approach to showing how a
mechanistic understanding of the differential gene expression can yield biomarkers that can be used
for early detection of disease, as well as potential therapeutic
targets.
When the mTORC1 (
for «
mechanistic target of rapamycin complex 1») pathway operates properly, it senses the amount of nutrients, specifically amino acids, available and restricts cell growth based on that level.
The protein complex GATOR1 (
for «GAP activity toward Rags») inhibits the mTOR (
for «
mechanistic target of rapamycin complex 1») pathway.
The structures of membrane - bound BCL - 2 proteins have been long sought - after because they hold the keys
for understanding the
mechanistic basis of activity and
for the development of selective drugs free of off -
target effects.
Our research will contribute to a better
mechanistic understanding of the microbes that live in our body, leading to the discovery of druggable small molecules, new
targets for antibacterial therapy and beneficial bacterial strains that can be employed
for intervention therapies.
This 3D proteomics brain data can be integrated with parallel 3D transcriptomic studies to possibly provide insights to interesting
targets for either therapeutic intervention or further
mechanistic studies.
We are interested in the
mechanistic function and structure of antimicrobial / antifungal proteins and peptides and the identification of
target molecules
for the development of new antimicrobial / antifungal therapies.
The
mechanistic target of rapamycin (mTOR) and the silent mating - type information regulation 2 homolog 1 (SIRT1): oversight
for neurodegenerative disorders
Our research will contribute to a better
mechanistic understanding of the microbes that live in our gut, leading to the discovery of druggable small molecules, new
targets for antibacterial therapy and beneficial bacterial strains that can be employed
for intervention therapies.
BETHESDA, MD, — The Foundation
for the National Institutes of Health (FNIH) has selected Whitehead Institute Member David Sabatini to receive its fifth annual Lurie Prize in Biomedical Sciences
for discovery of the mTOR (
mechanistic target of rapamycin) cellular pathway as a key regulator of growth and metabolism in response to nutrients.